” Even though the Ricaurte story was unfolding, MAPS eventually obtained FDA sign-off with a protocol for human trials of MDMA as a cure for PTSD, but only after it bought a $one million insurance plan coverage to indemnify the critique board.A study of youthful adult and adolescent consumers found that forty three% met the recognized diagnostic